Video: Knock on Wood| Webinar: ACR/CHEST ILD Guidelines in Practice
fa-facebookfa-linkedinfa-youtube-playfa-rss

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: Pre-eclampsia

Pre-Eclampsia Risk & Rheumatic Disease

Michele B. Kaufman, PharmD, BCGP  |  April 21, 2022

Secher et al. evaluated the risk of pre-eclampsia in pregnant patients with RA, axSpA or PsA, assessing the effect of disease activity and disease-modifying anti-rheumatic drugs on this risk.

Filed under:ACR ConvergenceConditionsDrug UpdatesMeeting Reports Tagged with:ACR Convergence 2021pregnancypregnancy complicationspregnant womenRheumatic DiseaseWomen

Coagulation Education: Treatment Options for Antiphospholipid Syndrome

Jason Liebowitz, MD, FACR  |  July 31, 2024

Dr. Maria Tektonidou discussed the latest recommendations for the treatment of patients with antiphospholipid syndrome (APS), including obstetric and thrombotic subtypes.

Filed under:ConditionsEULAR/OtherGuidanceMeeting ReportsVasculitis Tagged with:Antiphospholipid syndromeAPScardiovascularEULAR 2024obstetric APSpregnancypregnancy complicationsthrombotic APS

Pregnancy Outcomes in Patients Treated with TNF Inhibitors

Michele B. Kaufman, PharmD, BCGP  |  December 18, 2023

A study found the continuation of tumor necrosis factor inhibitor (TNFi) treatment in patients with chronic rheumatic inflammatory diseases after pregnancy diagnosis was not associated with worse outcomes than those who discontinued treatment with TNFi’s.

Filed under:ACR ConvergenceBiologics/DMARDsConditionsDrug UpdatesMeeting Reports Tagged with:ACR Convergence 2023pregnancypregnant womentumor necrosis factor inhibitor (TNFi)

Rheumatic Disease & Reproductive Health

Jason Liebowitz, MD, FACR  |  November 21, 2023

SAN DIEGO—In the Review Course at ACR Convergence 2023, Dr. Megan Clowse spoke on the subject of reproductive counseling for patients with rheumatic conditions, a topic that has been the focus of much of her research and scholarship.

Filed under:ACR ConvergenceConditionsMeeting Reports Tagged with:ACR Convergence 2023

Thrombotic Microangiopathies & Rheumatology

Jason Liebowitz, MD, FACR  |  November 16, 2023

SAN DIEGO—Thomas Ortel, MD, PhD, chief, Division of Hematology, Department of Medicine, Duke University School of Medicine, Durham, N.C., discussed thrombotic microangiopathies at ACR Convergence 2023. With a variety of causes, including autoimmune diseases, the connection with rheumatology is evident.

Filed under:ACR ConvergenceConditionsMeeting ReportsOther Rheumatic Conditions Tagged with:ACR Convergence 2023

Blood Is Thicker Than Water: Updates on the ACR/EULAR Antiphospholipid Syndrome Classification Criteria

Jason Liebowitz, MD, FACR  |  December 12, 2022

PHILADELPHIA—Ever since the seminal work of C. Lockard Conley, MD, in 1952 of the discovery of the lupus anticoagulant, antiphospholipid syndrome (APS) has been of great interest to rheumatologists, hematologists and many others. At ACR Convergence 2022, the session titled Draft ACR/EULAR Antiphospholipid Syndrome Classification Criteria sought to summarize the rigorous process that went into…

Filed under:ACR ConvergenceConditionsMeeting ReportsOther Rheumatic Conditions Tagged with:ACR Convergence 2022Antiphospholipid Antibody Syndrome (APS)

From Contraception to Breastfeeding: Experts Address Reproductive Health & Medication Management

Mithu Maheswaranathan, MD  |  November 11, 2021

ACR CONVERGENCE 2021—Rheumatologists are often left in a challenging space when managing medications for patients with rheumatic diseases in relation to contraception, pregnancy and breastfeeding, especially with many novel immunosuppressants and often a dearth of pregnancy safety data. On Nov. 6 during ACR Convergence 2021, leading reproductive health experts came together to speak on this…

Filed under:ACR ConvergenceConditionsMeeting Reports Tagged with:ACR Convergence 2021breastfeedingcontraceptivepregnancyreproductive health

Hope for Live Births in Women with Antiphospholipid Syndrome

Lara C. Pullen, PhD  |  September 14, 2020

For women with antiphospholipid syndrome (APS), treatment with a combination of heparin and aspirin during pregnancy—rather than aspirin alone—may increase live birth rates, according to new research.

Filed under:ConditionsOther Rheumatic Conditions Tagged with:Antiphospholipid Antibody Syndrome (APS)birthHughes Syndromepregnancypregnant women

Baby on Board: The Rheumatologist’s Role in Family Planning for Patients with Lupus

Jason Liebowitz, MD, FACR  |  January 2, 2020

For patients with lupus, family planning discussions are vital to achieving positive pregnancy outcomes & maintaining overall health…

Filed under:ConditionsSystemic Lupus Erythematosus Tagged with:family planningLupuspregnancypregnancy complicationssystemic lupus erythematosus (SLE)Women

Complications to Watch for in Pregnant Rheumatology Patients

Anat Chemerinski, MD, & Jason Liebowitz, MD  |  November 18, 2018

BALTIMORE—Understanding issues regarding pregnancy in women with rheumatic disease is important to patients and physicians alike, said Bonnie Bermas, MD, the Dr. Morris Ziff Distinguished Professor in Rheumatology at UT Southwestern Medical Center, Dallas, in her recent lecture at the Maryland Society for the Rheumatic Diseases.The physiologic changes in normal pregnancy, which include increased circulating…

Filed under:ConditionsMeeting Reports Tagged with:pregnancy

  • 1
  • 2
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
fa-facebookfa-linkedinfa-youtube-playfa-rss
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences